S.Amdt. 3144Senate119th Congress (2025-2027)
S.Amdt. 3144
Sponsored by
Sen. Ted Budd (R-NC)
Submitted July 30, 2025
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
July 30, 2025
Text
Submitted
SA 3144. Mr. BUDD (for himself and Mr. Heinrich) submitted an amendment intended to be proposed by him to the bill H.R. 3944, making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2026, and for other purposes; which was ordered to lie on the table; as follows: At the appropriate place in division B, insert the following: [[Page S4924]] Sec. __. The Food and Drug Administration shall utilize existing regulatory and enforcement authorities to prevent the importation of GLP-1 and GIP/GLP-1 drugs that appear to be counterfeit, unapproved, misbranded, or adulterated from the Republic of China or other foreign countries, including any bulk drug substance or active pharmaceutical ingredient from facilities in China. Such regulatory and enforcement authorities include issuing warning letters, initiating civil enforcement actions, and refusing the entry of drugs, including bulk drug substances, and active pharmaceutical ingredients used in drugs from such facilities. ______